(via TheNewswire)
The Company made the decision to hold the Meeting by teleconference after considering Provincial and Federal guidance regarding public gatherings, and to proactively protect the health and wellbeing of the Company’s shareholders, officers, directors and service providers that will participate in the Meeting.
The Company encourages its shareholders to vote their common shares before the proxy cut-off date of
Shareholders who wish to attend the Meeting can find the details to attend below.
Dial in for any other countries, please contact the Company at 604.737.2303 prior to the Meeting date for dial in particulars.
How to Vote:
- Registered shareholdersof the Company will be able to vote their common shares online atwww.investorvote.comor by telephone (1-866-732-VOTE (8683) (Toll Free)). The Registered shareholders will require their control number which can be found on their proxy form that will be mailed out to the Company’s shareholders on or before
Friday, March 19, 2021 .- Non-objecting beneficial(“NOBO”)shareholdersof the Company will be able to vote common shares online atwww.investorvote.comor by telephone (1-866-734-VOTE (8683) (Toll Free)). The NOBO holders will require their control number which can be found on their voting instruction form.
- Objecting beneficial shareholdersof the Company must contact their broker directly to obtain their proxy form to vote their common shares.
About
Sire is headquartered in
For additional information contact:
T: 416.669.9392
E: ir@sirebioscience.com
W: sirebioscience.com
Socials: @sirebioscience
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2021 TheNewswire - All rights reserved.
Copyright (c) 2021 TheNewswire - All rights reserved., source